Company intelligence
CureSHANK
Relentlessly focused on turning promising science into life-transforming therapies for Phelan-McDermid syndrome.
Research Services
Beverly Hills, US
13 employees
Founded 2019
5 public signals
About CureSHANK
CureSHANK is a nonprofit foundation whose mission is to accelerate the development of treatments for SHANK-associated disorders, specifically Phelan-McDermid Syndrome. Our approach is to identify and fund projects that overcome critical barriers to successful drug development and to coordinate scientific efforts to improve efficiency and speed in the field.
Verified activity
Signals from CureSHANK
5 published signals
Research & Knowledge
CureSHANK is actively working with experts to evaluate promising biomarker approaches for PMS therapy development.
Reported by CureSHANK
Research & Knowledge
CureSHANK updated eligibility criteria for the PMS Caregiver Milestone Study.
Reported by CureSHANK
Research & Knowledge
CureSHANK opened new active sites for the PMS Koala Study, bringing the total number of active sites up to 16.
Reported by CureSHANK
Research & Knowledge
CureSHANK is participating in a clinical research study testing a novel at-home EEG device to study sleep in children with profound autism or cognitive impairment.
Reported by CureSHANK
Research & Knowledge
CureSHANK announced that a Phase 3 Clinical Trial in Children with Phelan-McDermid Syndrome (PMS), KOALA, is currently enrolling participants with 16 sites activated.
Reported by CureSHANK